70.36
Invesco Biotechnology Genome Etf stock is traded at $70.36, with a volume of 7,729.
It is down -1.66% in the last 24 hours and up +0.58% over the past month.
See More
Previous Close:
$71.55
Open:
$71.68
24h Volume:
7,729
Relative Volume:
0.88
Market Cap:
$281.93M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-3.23%
1M Performance:
+0.58%
6M Performance:
+24.34%
1Y Performance:
+3.39%
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
Name
Invesco Biotechnology Genome Etf
Sector
Industry
Phone
-
Address
-
Compare PBE with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
PBE
Invesco Biotechnology Genome Etf
|
70.36 | 281.93M | 0 | 0 | 0 | 0.00 |
![]()
VTI
Vanguard Total Stock Market Etf
|
321.80 | 417.53B | 0 | 0 | 0 | 0.00 |
![]()
SPY
Spdr S P 500 Etf Trust
|
653.02 | 372.57B | 0 | 0 | 0 | 0.00 |
![]()
IVV
Ishares Core S P 500 Etf
|
656.20 | 253.41B | 0 | 0 | 0 | 0.00 |
![]()
VB
Vanguard Small Cap Etf
|
248.10 | 160.59B | 0 | 0 | 0 | 0.00 |
![]()
QQQ
Invesco Qqq Trust Series 1
|
589.50 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf Stock (PBE) Latest News
Wealth Enhancement Advisory Services LLC Sells 2,491 Shares of Invesco Biotechnology & Genome ETF $PBE - Defense World
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - sharewise.com
Genome ETF stock benefit from mergersTrade Risk Summary & Consistent Return Strategy Ideas - newser.com
The Best Biotech ETFs to Buy - Kiplinger
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - MSN
Genome ETF stock deliver strong annual returnsJuly 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Genome ETF stock2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - Benzinga
Signet Financial Management LLC Grows Position in Invesco Biotechnology & Genome ETF $PBE - Defense World
Invesco Biotechnology & Genome ETF $PBE Position Decreased by HighTower Advisors LLC - Defense World
7 Best Biotech ETFs to Buy Now - US News Money
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Sold by LPL Financial LLC - Defense World
Cetera Investment Advisers Has $1.34 Million Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Acquired by Private Advisor Group LLC - Defense World
Invesco (IVZ) Rallies 0.18% to Highest Since July 2025 Amid Asset Management Sector Reassessment - AInvest
PBE ETF: A Comprehensive Guide to Its Fundamentals and Performance - AInvest
Should You Invest in the Invesco S&P 500 Equal Weight Financials ETF (RSPF)? - Yahoo Finance
Invesco Nasdaq Biotechnology ETF IBBQ 2025Q2 Earnings Preview Upside Potential on Biotech Sector Growth - AInvest
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Purchased by Wealth Enhancement Advisory Services LLC - Defense World
Janney Montgomery Scott LLC Has $344,000 Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Invesco Exchange-Traded Fund TrustInvesco Biotechnology & Genome ETF Reports Earnings Results for the Full Year Ended April 30, 2025 - MarketScreener
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Short Interest Update - Defense World
Farther Finance Advisors LLC Acquires 6,201 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Wealth Enhancement Advisory Services LLC Raises Stake in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Two Sigma Investments LP Cuts Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
PDS Biotechnology (NASDAQ:PDSB) Receives Buy Rating from HC Wainwright - Defense World
Citadel Advisors LLC Grows Stake in Innovator U.S. Equity Ultra Buffer ETF – January (BATS:UJAN) - Defense World
8,551 Shares in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Acquired by Citadel Advisors LLC - Defense World
Bank of America Corp DE Has $4.59 Million Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Stake Lessened by Cetera Investment Advisers - Defense World
Stifel Financial Corp Acquires 16,892 Shares of RiverNorth Managed Duration Municipal Income Fund II, Inc. (NYSEARCA:RMMZ) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Tower Research Capital LLC TRC - Defense World
Stifel Financial Corp Sells 600 Shares of SRH Total Return Fund, Inc. (NYSE:STEW) - Defense World
Stifel Financial Corp Sells 1,457 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Stifel Financial Corp Grows Stock Holdings in Schwab U.S. REIT ETF (NYSEARCA:SCHH) - Defense World
Susquehanna International Group LLP Makes New Investment in VictoryShares Core Intermediate Bond ETF (NASDAQ:UITB) - Defense World
Stifel Financial Corp Acquires 5,291 Shares of T. Rowe Price Dividend Growth ETF (NYSEARCA:TDVG) - Defense World
Hsbc Holdings PLC Grows Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Hsbc Holdings PLC Purchases 16,554 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
Barclays PLC Buys 10,174 Shares of FT Vest U.S. Equity Enhance & Moderate Buffer ETF – January (NYSEARCA:XJAN) - Defense World
16,974 Shares in VNET Group, Inc. (NASDAQ:VNET) Bought by Tower Research Capital LLC TRC - Defense World
Tower Research Capital LLC TRC Lowers Position in The Marcus Co. (NYSE:MCS) - Defense World
Hsbc Holdings PLC Has $232,000 Stock Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World
Hsbc Holdings PLC Takes Position in Vir Biotechnology, Inc. (NASDAQ:VIR) - Defense World
Tower Research Capital LLC TRC Has $71,000 Holdings in CTO Realty Growth, Inc. (NYSE:CTO) - Defense World
Dimensional Fund Advisors LP Raises Stake in REGENXBIO Inc. (NASDAQ:RGNX) - Defense World
Dimensional Fund Advisors LP Raises Holdings in Blue Foundry Bancorp (NASDAQ:BLFY) - Defense World
Klaviyo, Inc. (NYSE:KVYO) Shares Bought by Tower Research Capital LLC TRC - Defense World
Invesco Biotechnology Genome Etf Stock (PBE) Financials Data
There is no financial data for Invesco Biotechnology Genome Etf (PBE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):